Donald N Cook1. 1. Immunogenetics Group, Immunity, Inflammation and Disease Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, 111 T.W. Alexander Dr., Research Triangle Park, Durham, NC, 27709, USA. cookd@niehs.nih.gov.
Abstract
PURPOSE OF REVIEW: This review summarizes recent progress in our understanding how environmental adjuvants promote the development of asthma. RECENT FINDINGS: Asthma is a heterogeneous set of lung pathologies with overlapping features. Human studies and animal models suggest that exposure to different environmental adjuvants activate distinct immune pathways, which in turn give rise to distinct forms, or endotypes, of allergic asthma. Depending on their concentrations, inhaled TLR ligands can activate either type 2 inflammation, or Th17 differentiation, along with regulatory responses that function to attenuate inflammation. By contrast, a different category of environmental adjuvants, proteases, activate distinct immune pathways and prime predominantly type 2 immune responses. Asthma is not a single disease, but rather a group of pathologies with overlapping features. Different endotypes of asthma likely arise from perturbations of distinct immunologic pathways during allergic sensitization.
PURPOSE OF REVIEW: This review summarizes recent progress in our understanding how environmental adjuvants promote the development of asthma. RECENT FINDINGS:Asthma is a heterogeneous set of lung pathologies with overlapping features. Human studies and animal models suggest that exposure to different environmental adjuvants activate distinct immune pathways, which in turn give rise to distinct forms, or endotypes, of allergic asthma. Depending on their concentrations, inhaled TLR ligands can activate either type 2 inflammation, or Th17 differentiation, along with regulatory responses that function to attenuate inflammation. By contrast, a different category of environmental adjuvants, proteases, activate distinct immune pathways and prime predominantly type 2 immune responses. Asthma is not a single disease, but rather a group of pathologies with overlapping features. Different endotypes of asthma likely arise from perturbations of distinct immunologic pathways during allergic sensitization.
Authors: Matam Vijay-Kumar; Jesse D Aitken; Frederic A Carvalho; Tyler C Cullender; Simon Mwangi; Shanthi Srinivasan; Shanthi V Sitaraman; Rob Knight; Ruth E Ley; Andrew T Gewirtz Journal: Science Date: 2010-03-04 Impact factor: 47.728
Authors: Rhonda H Wilson; Gregory S Whitehead; Hideki Nakano; Meghan E Free; Jay K Kolls; Donald N Cook Journal: Am J Respir Crit Care Med Date: 2009-08-06 Impact factor: 21.405
Authors: Richard Y Kim; James W Pinkerton; Ama T Essilfie; Avril A B Robertson; Katherine J Baines; Alexandra C Brown; Jemma R Mayall; M Khadem Ali; Malcolm R Starkey; Nicole G Hansbro; Jeremy A Hirota; Lisa G Wood; Jodie L Simpson; Darryl A Knight; Peter A Wark; Peter G Gibson; Luke A J O'Neill; Matthew A Cooper; Jay C Horvat; Philip M Hansbro Journal: Am J Respir Crit Care Med Date: 2017-08-01 Impact factor: 21.405
Authors: John M Brehm; Sima K Ramratnam; Sze Man Tse; Damien C Croteau-Chonka; Maria Pino-Yanes; Christian Rosas-Salazar; Augusto A Litonjua; Benjamin A Raby; Nadia Boutaoui; Yueh-Ying Han; Wei Chen; Erick Forno; Anna L Marsland; Nicole R Nugent; Celeste Eng; Angel Colón-Semidey; María Alvarez; Edna Acosta-Pérez; Melissa L Spear; Fernando D Martinez; Lydiana Avila; Scott T Weiss; Manuel Soto-Quiros; Carole Ober; Dan L Nicolae; Kathleen C Barnes; Robert F Lemanske; Robert C Strunk; Andrew Liu; Stephanie J London; Frank Gilliland; Patrick Sleiman; Michael March; Hakon Hakonarson; Qing Ling Duan; Jay K Kolls; Gregory K Fritz; Donglei Hu; Negar Fani; Jennifer S Stevens; Lynn M Almli; Esteban G Burchard; Jaemin Shin; Elizabeth L McQuaid; Kerry Ressler; Glorisa Canino; Juan C Celedón Journal: Am J Respir Crit Care Med Date: 2015-07-01 Impact factor: 21.405
Authors: Hamida Hammad; Marcello Chieppa; Frederic Perros; Monique A Willart; Ronald N Germain; Bart N Lambrecht Journal: Nat Med Date: 2009-03-29 Impact factor: 53.440
Authors: Michelle M Stein; Cara L Hrusch; Justyna Gozdz; Erika von Mutius; Donata Vercelli; Carole Ober; Anne I Sperling; Catherine Igartua; Vadim Pivniouk; Sean E Murray; Julie G Ledford; Mauricius Marques Dos Santos; Rebecca L Anderson; Nervana Metwali; Julia W Neilson; Raina M Maier; Jack A Gilbert; Mark Holbreich; Peter S Thorne; Fernando D Martinez Journal: N Engl J Med Date: 2016-08-04 Impact factor: 91.245
Authors: Frederick J Rubner; Daniel J Jackson; Michael D Evans; Ronald E Gangnon; Christopher J Tisler; Tressa E Pappas; James E Gern; Robert F Lemanske Journal: J Allergy Clin Immunol Date: 2016-05-10 Impact factor: 10.793
Authors: J A Tuazon; B Kilburg-Basnyat; L M Oldfield; R Wiscovitch-Russo; K Dunigan-Russell; A V Fedulov; K J Oestreich; K M Gowdy Journal: Curr Allergy Asthma Rep Date: 2022-04-08 Impact factor: 4.919
Authors: Gregory S Whitehead; Seddon Y Thomas; Keiko Nakano; Derek J Royer; Catherine G Burke; Hideki Nakano; Donald N Cook Journal: JCI Insight Date: 2022-02-22
Authors: Christoph Bergmann; Aurélie Poli; Ioana Agache; Rodolfo Bianchini; Heather J Bax; Mariana Castells; Silvia Crescioli; David Dombrowicz; Denisa Ferastraoaru; Edda Fiebiger; Hannah J Gould; Karin Hartmann; Elena Izquierdo; Galateja Jordakieva; Debra H Josephs; Marek Jutel; Francesca Levi-Schaffer; Leticia de Las Vecillas; Michael T Lotze; Gabriel Osborn; Mariona Pascal; Frank Redegeld; David Rosenstreich; Franziska Roth-Walter; Carsten Schmidt-Weber; Mohamed Shamji; Esther H Steveling; Michelle C Turner; Eva Untersmayr; Erika Jensen-Jarolim; Sophia N Karagiannis Journal: Allergy Date: 2022-03-14 Impact factor: 14.710